AnPac Bio-Medical Science Co. (ANPC) Reports H1'22 Results :

AnPac Bio-Medical Science Co. (ANPC) Reports H1'22 Results

AnPac Bio-Medical Science Co. (ANPC) Reports H1'22 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Weitou , Fujian , China , Taiwan , Shanghai , United States , Xiaoyu Li , Anhui , Chang Yu , Hunan , Guo Feng , Honggang , Heilongjiang , Xing Pu , Delaware , Changwei , Hainan , Haohan Xu , Yuyang Cui , Chris Chang Yu , Jianhua Shao , Chris Yu , Jiawen Kang , Llctina Xiao , Ren Luo , Zhigang Frank Zhao , Anpac Bio , Tianruo Robert Pu , Changwei System Technology Shanghai Co Ltd , Company American Depositary Shares Adss , Hunan Weitou Scientific Technology Co Ltd , Science Co Ltd , Nasdaq , Exchange Commission , Listing Qualifications Department , Development Expenses , Delaware Court , American Association For Cancer Research , Hearings Panel , Nasdaq Stock Market , Securities Exchange , Company Of The Staff , Wall Street , Pac Bio Medical Science , First Half , Registered Convertible Debentures , Ascent Convertible Debentures , Nasdaq Capital Market , General Counsel , Listed Securities , Listing Rule , Mandatory Panel Monitor , American Association , Cancer Research , Financial Results , Anpai Shanghai , Changwei System Technology , Shanghai Stonedrop Investment Management , Co Chief Executive Officer , Co Chief Financial Officer , American Depositary Shares , Chen Wenge , Stock Repurchase Agreement , Pac Bio , Cancer Differentiation Analysis , Phil Case , Investor Relationsphone , Ascent Investor Relations , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Months Ended June ,